In-depth profiling of tumor tissue derived from malignant pleural mesothelioma patients identifies potential biomarkers predicting response to immune-checkpoint inhibitor therapy.

ABSTRACT:

SUBMITTER: Shek D 

PROVIDER: S-EPMC11298826 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature